BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28643086)

  • 1. Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major.
    Alves MMM; Brito LM; Souza AC; Queiroz BCSH; de Carvalho TP; Batista JF; Oliveira JSSM; de Mendonça IL; Lira SRS; Chaves MH; Gonçalves JCR; Carneiro SMP; Arcanjo DDR; Carvalho FAA
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):893-903. PubMed ID: 28643086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallic and Ellagic Acids Are Promising Adjuvants to Conventional Amphotericin B for the Treatment of Cutaneous Leishmaniasis.
    Alves MMM; Arcanjo DDR; Figueiredo KA; Oliveira JSSM; Viana FJC; Coelho ES; Lopes GLN; Gonçalves JCR; Carvalho ALM; Rizzo MDS; Chaves MH; Mendonça IL; Carvalho FAA
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antileishmanial and immunomodulatory activities of the synthetic analogue riparin E.
    Costa LM; Muálem de Moraes Alves M; Brito LM; de Araujo Abi-Chacra E; Barbosa-Filho JM; Chavez Gutierrez SJ; Barreto HM; Aécio de Amorim Carvalho F
    Chem Biol Interact; 2021 Feb; 336():109389. PubMed ID: 33484715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
    Gutiérrez J; Vallejo B; Barbosa H; Pinzón J; Delgado G
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):321-8. PubMed ID: 23473403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial potential of immunomodulator gallic acid against experimental murine visceral leishmaniasis.
    Keshav P; Goyal DK; Kaur S
    Parasite Immunol; 2021 Oct; 43(10-11):e12875. PubMed ID: 34347892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fe3O4
    Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
    Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects.
    Noleto Dias C; Nunes TAL; Sousa JMS; Costa LH; Rodrigues RRL; Araújo AJ; Marinho Filho JDB; da Silva MV; Oliveira MR; Carvalho FAA; Rodrigues KADF
    Chem Biol Interact; 2020 Apr; 320():109026. PubMed ID: 32112863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo comparative effects of the spring and autumn-harvested Artemisia aucheri Bioss extracts on Leishmania major.
    KarimiPourSaryazdi A; Ghaffarifar F; Dalimi A; Dayer MS
    J Ethnopharmacol; 2020 Jul; 257():112910. PubMed ID: 32344159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
    Bemani E; Oryan A; Bahrami S
    Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garcinielliptone FC: Selective anti-amastigote and immunomodulatory effects on macrophages infected by Leishmania amazonensis.
    Bezerra ÉA; Alves MMM; Amorim LV; Carvalho RCV; Cruz LPL; Costa-Júnior JS; Oliveira MDDA; Lima Neto JS; Carvalho FAA; Citó AMDGL; Arcanjo DDR
    Toxicol In Vitro; 2020 Mar; 63():104750. PubMed ID: 31862617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J; Moreno E; Calvo A; Blanco L; Fernández-Rubio C; Sanmartín C; Nguewa P; Irache JM; Larrea E; Espuelas S
    J Dermatol Sci; 2018 Oct; 92(1):78-88. PubMed ID: 30037731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of leishmanicidal activity and cytotoxicity of Ricinus communis and Azadirachta indica extracts from western Kenya: in vitro and in vivo assays.
    Jumba BN; Anjili CO; Makwali J; Ingonga J; Nyamao R; Marango S; Choge JK; Khayeka-Wandabwa C
    BMC Res Notes; 2015 Nov; 8():650. PubMed ID: 26541197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model.
    Keshav P; Goyal DK; Kaur S
    Med Microbiol Immunol; 2023 Feb; 212(1):35-51. PubMed ID: 36399160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of manganese oxide (Mn
    Tavakoli P; Ghaffarifar F; Delavari H; Shahpari N
    J Trace Elem Med Biol; 2019 Dec; 56():162-168. PubMed ID: 31473559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis.
    Gervazoni LFO; Gonçalves-Ozório G; Almeida-Amaral EE
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006930. PubMed ID: 30521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.